Related Experiment Video
Updated: Jul 1, 2026

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
Caffeine does not modulate inhibitory control
Zoë Tieges1, Jan Snel, Albert Kok
1Department of Psychology, University of Amsterdam, Roetersstraat 15, 1018 WB Amsterdam, The Netherlands.
Abstract:
The effects of a 3mg/kg body weight (BW) dose of caffeine were assessed on behavioral indices of response inhibition. To meet these aims, we selected a modified AX version of the Continuous Performance Test (CPT), the stop task, and the flanker task. In three double-blind, placebo-controlled, within-subjects experiments, these tasks were administered to healthy participants. While the results for the AX-CPT were indicative of improved response inhibition after caffeine, they might also reflect caffeine-induced changes in mechanisms other than response inhibition (e.g., attentional processes). The results for the stop task and flanker task were more straightforward. That is, the effects of caffeine on overall flanker performance and selective response suppression as revealed by distribution-analytical techniques were negligible. In the stop task a global effect of caffeine on processing speed was seen, rather than specific effects on response inhibition. Taken together, these experiments showed that both active and reactive inhibition were not significantly modulated by caffeine. The present results are linked to neural circuits that underlie inhibitory control and the role of caffeine-induced strategic changes.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Feedback Inhibition
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS Depressants: Alcohol and Nicotine
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Inhibition of Cdk Activity

